One for Santa’s wish list is a standard recommended daily amount for Glucosamine Sulphate. Whilst children of the land will wake to wishes coming true next week, the confusion for consumers about Glucosamine Sulphate is likely to rumble till Christmas 2019.
Three months on from the 05 Sept 2018 announcement from the MHRA that Glucosamine food supplements can only be sold if they are lower than 1178mg glucosamine base per daily dose, changes to labelling are beginning to take effect. The original full article can be read via this link.
This government statement took effect immediately, with food supplement manufacturers having to take prompt action. No sell through date or transition period was announced or granted.
Glucosamine containing products (GCPs) especially glucosamine sulphate food supplements until this date were sold as a variety of strengths, all resulting in a recommended total daily dose of 1500mg Glucosamine Sulphate.
On 06 November the Pharmaceutical Services negotiating Committee (PSNC), who promote and support the interests of all NHS community pharmacies in England offered the following advice.
MHRA have advised that affected GCPs should be removed from counter and dispensary shelves to avoid the inadvertent sale or supply of unauthorised medicinal products. Any prescriptions received for GCPs with a daily dose of base glucosamine at 1178mg which cannot be met by a licensed product should be referred back to the prescriber.
GCPs that can no longer be dispensed or sold over-the-counter as food supplements are GCPs with a daily dose of base glucosamine at 1178mg/day or higher
GCPs that can legally be dispensed or sold over-the-counter as food supplements are GCPs with a daily dose of base glucosamine less than 1178mg